HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Zhu Selected Research

VAP-cyclo protocol

3/2015Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.
1/2014Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma.
10/2010[Treatment outcome analysis of CTOP or CHOP regimen in newly diagnosed aggressive non-Hodgkin's lymphoma patients-results of a prospective, open, randomized, multicenter clinical trial].
3/2006Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
12/2005[Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Zhu Research Topics

Disease

180Neoplasms (Cancer)
11/2022 - 08/2002
43Atrial Fibrillation
08/2022 - 09/2009
42Infections
01/2022 - 10/2006
40Stroke (Strokes)
12/2022 - 12/2004
36Myocardial Infarction
12/2022 - 12/2004
33Hemorrhage
10/2022 - 01/2005
32Lymphoma (Lymphomas)
12/2021 - 08/2003
31Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2022 - 12/2005
30Inflammation (Inflammations)
08/2022 - 10/2006
29Neoplasm Metastasis (Metastasis)
01/2022 - 07/2005
24Heart Failure
01/2022 - 01/2005
22Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 06/2009
21Coronary Artery Disease (Coronary Atherosclerosis)
12/2022 - 05/2008
20Breast Neoplasms (Breast Cancer)
05/2022 - 07/2003
20Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 12/2005
19Congenital Heart Defects (Congenital Heart Defect)
01/2022 - 01/2013
18Carcinogenesis
01/2022 - 06/2012
18Hypertension (High Blood Pressure)
01/2022 - 02/2005
17ST Elevation Myocardial Infarction
02/2016 - 01/2005
16B-Cell Lymphoma (Lymphoma, B Cell)
10/2022 - 01/2007
15Lung Neoplasms (Lung Cancer)
02/2022 - 12/2007
15Stomach Neoplasms (Stomach Cancer)
01/2022 - 10/2006
15Type 2 Diabetes Mellitus (MODY)
01/2022 - 12/2012
15Colorectal Neoplasms (Colorectal Cancer)
07/2021 - 10/2006
14Hypoxia (Hypoxemia)
01/2022 - 01/2007
13Hodgkin Disease (Hodgkin's Disease)
01/2022 - 10/2011
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2021 - 12/2007
12Fibrosis (Cirrhosis)
07/2022 - 02/2012
12Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2022 - 04/2006
12T-Cell Lymphoma (Lymphoma, T Cell)
01/2022 - 03/2006
12Embolism (Embolus)
01/2022 - 09/2009
12Obesity
01/2021 - 02/2005
10Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 07/2012
10Cholera
12/2021 - 03/2003
10Hepatocellular Carcinoma (Hepatoma)
01/2021 - 07/2005
10Leukemia
01/2018 - 06/2006
9Carcinoma (Carcinomatosis)
02/2022 - 01/2016
9Diabetes Mellitus
01/2022 - 02/2005
9Melanoma (Melanoma, Malignant)
08/2021 - 01/2007
9Hypersensitivity (Allergy)
01/2021 - 07/2009
8Male Infertility (Male Sterility)
10/2022 - 01/2012
8Pain (Aches)
09/2022 - 12/2012
8Acute Coronary Syndrome
08/2022 - 05/2011
8Urinary Bladder Neoplasms (Bladder Cancer)
02/2022 - 03/2011
8Body Weight (Weight, Body)
01/2022 - 01/2013
7Peripheral Arterial Disease
12/2022 - 01/2017
7Rheumatoid Arthritis
10/2022 - 01/2011
7Diarrhea
01/2022 - 11/2007
7Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 09/2013
7Wounds and Injuries (Trauma)
11/2021 - 07/2005
7Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2021 - 01/2014
7Lymphatic Metastasis
01/2021 - 12/2007
7Infarction (Infarctions)
10/2020 - 04/2005

Drug/Important Bio-Agent (IBA)

57Proteins (Proteins, Gene)FDA Link
11/2022 - 04/2004
40Biomarkers (Surrogate Marker)IBA
02/2022 - 08/2006
35MicroRNAs (MicroRNA)IBA
01/2022 - 12/2010
34Pharmaceutical PreparationsIBA
02/2022 - 08/2002
32Rituximab (Mabthera)FDA Link
12/2022 - 01/2007
30RNA (Ribonucleic Acid)IBA
08/2022 - 08/2005
29Glucose (Dextrose)FDA LinkGeneric
10/2022 - 12/2004
26Biological ProductsIBA
10/2022 - 01/2009
19Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2022 - 01/2005
17omega-Chloroacetophenone (Mace)IBA
10/2022 - 06/2009
17Messenger RNA (mRNA)IBA
07/2022 - 07/2005
17Doxorubicin (Adriamycin)FDA LinkGeneric
10/2021 - 08/2003
16Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2022 - 08/2003
16Vincristine (Oncovin)FDA LinkGeneric
12/2022 - 08/2003
16CholesterolIBA
01/2021 - 02/2005
15Warfarin (Coumadin)FDA LinkGeneric
01/2022 - 09/2009
12Prednisone (Sone)FDA LinkGeneric
12/2022 - 09/2014
12AnticoagulantsIBA
08/2022 - 01/2008
12Therapeutic UsesIBA
08/2021 - 01/2007
11Long Noncoding RNAIBA
09/2022 - 01/2018
11CytokinesIBA
01/2022 - 10/2010
10RivaroxabanIBA
12/2022 - 01/2017
10Immune Checkpoint InhibitorsIBA
01/2022 - 01/2018
10ibrutinibIBA
01/2022 - 04/2014
10Insulin (Novolin)FDA Link
01/2021 - 12/2004
10Small Interfering RNA (siRNA)IBA
01/2019 - 03/2011
9EnzymesIBA
11/2022 - 06/2009
9Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2014
9DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2013
9Agammaglobulinaemia Tyrosine KinaseIBA
01/2022 - 06/2017
9Triglycerides (Triacylglycerol)IBA
12/2020 - 02/2005
9Transcription Factors (Transcription Factor)IBA
01/2020 - 06/2010
9apixabanIBA
01/2018 - 03/2011
8Asparaginase (Elspar)FDA Link
09/2022 - 08/2003
8LipidsIBA
01/2022 - 11/2011
8Oxygen (Dioxygen)IBA
12/2021 - 01/2016
8LDL CholesterolIBA
08/2020 - 02/2005
7Hemoglobins (Hemoglobin)IBA
08/2022 - 11/2011
7CollagenIBA
07/2022 - 02/2012
7Chimeric Antigen ReceptorsIBA
01/2022 - 01/2019
7Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 08/2015
7Phosphotransferases (Kinase)IBA
10/2021 - 02/2013

Therapy/Procedure

131Therapeutics
10/2022 - 11/2002
58Drug Therapy (Chemotherapy)
01/2022 - 08/2002
17Radiotherapy
01/2022 - 08/2009
15Immunotherapy
10/2022 - 04/2014
10Percutaneous Coronary Intervention
08/2022 - 01/2005